Followers | 680 |
Posts | 141062 |
Boards Moderated | 36 |
Alias Born | 03/10/2004 |
Monday, December 10, 2018 7:53:03 AM
By: Engadget | December 9, 2018
It's another instance of internet giants seemingly ignoring major crises.
Unfortunately, social network leaders still appear to be tone deaf regarding Myanmar's reported atrocities. Twitter chief Jack Dorsey posted a series of tweets encouraging followers to visit Myanmar after he'd been there for a birthday meditation retreat, seemingly ignoring widespread evidence of the country's government committing genocide against the Rohingya people and forcing hundreds of thousands of them to flee. He focused solely on his trip, noting that the "people are full of joy" and celebrating the experience of listening to a Kendrick Lamar album after breaking silence.
As the New York Times' Liam Stack noted, the issue isn't just that Dorsey completely sidestepped the Myanmar government's actions -- it's that he did so despite social networking (mainly Facebook) playing an instrumental role in fostering massacres and other crimes.
We've asked Twitter for comment. However, it's reasonable to presume that Dorsey's Myanmar endorsement won't help Twitter persuade the public that it's responsive to complaints. People have already accused the company of being reluctant to remove some of its most toxic users, and now its CEO appears to have glossed over a government's horrific acts while touting his own journey of self-discovery.
jack
?
@jack
For my birthday this year, I did a 10-day silent vipassana meditation, this time in Pyin Oo Lwin, Myanmar . We went into silence on the night of my birthday, the 19th. Here’s what I know
10.7K
7:19 PM - Dec 8, 2018 · San Francisco, CA
Twitter Ads info and privacy
4,591 people are talking about this
Read More »»»
• DiscoverGold
Information posted to this board is not meant to suggest any specific action, but to point out the technical signs that can help our readers make their own specific decisions. Your Due Dilegence is a must!
• DiscoverGold
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM